Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037967 | SCV000061633 | benign | not specified | 2016-06-14 | criteria provided, single submitter | clinical testing | p.Glu21Glu in exon 1 of NKX2-5: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 67% (6119/9090) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broa dinstitute.org; dbSNP rs2277923). |
Eurofins Ntd Llc |
RCV000037967 | SCV000112983 | benign | not specified | 2013-06-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000037967 | SCV000170768 | benign | not specified | 2013-01-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000037967 | SCV000194074 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000037967 | SCV000310345 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000621997 | SCV000735010 | benign | Cardiovascular phenotype | 2015-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001519748 | SCV001728673 | benign | Atrial septal defect 7 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000037967 | SCV001741236 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000037967 | SCV001918588 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000037967 | SCV001933009 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037967 | SCV001954470 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000037967 | SCV001973173 | benign | not specified | no assertion criteria provided | clinical testing |